This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. Prasad Panzade, PhD
Vice President, Research and Development at Nitto Avecia
Speaker

Profile

Dr. Prasad Panzade is a seasoned executive with over 25 years of experience in the chemical industries, including pharmaceuticals and biopharmaceuticals. Known for his strategic, entrepreneurial mindset and broad vision, Dr. Panzade holds a Ph.D. in Pharmaceutical Sciences, specializing in pharmaceutical product development, Analytical Sciences and Technology. He is an active member of numerous professional organizations and a dedicated mentor who focuses on cultivating future leaders.

Currently serving as the Vice President of Research and Development - CMC at Nitto Avecia, Dr. Panzade has previously held leadership roles in global R&D at Catalent, a leading CDMO, and at Apotex Inc., Canada’s largest generic pharmaceutical company. Prior to these roles, he served as Senior Vice President at the Aditya Birla Group, a multibillion-dollar conglomerate. Throughout his career, Dr. Panzade has held various senior positions across the API, specialty chemicals, polymer, and generic drug formulation sectors.

A recognized speaker in the field of pharmaceutical sciences, Dr. Panzade shares his expertise through conferences and publications. He has authored several peer-reviewed journal articles and holds 2 patents. Earlier in his career, he also taught as a pharmaceutical college lecturer before transitioning to leadership roles in industry.

Agenda Sessions

  • Advancing Sustainability in the Oligonucleotides Industry: Strategies for Environmental Responsibility and Innovation

    12:05pm